Atlas Trials

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

Clinical trial NCT05003479 · UNKNOWN

Trial details

NCT number
NCT05003479
Sponsor
Shenzhen Kangtai Biological Products Co., LTD
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2021-08-01
Primary completion
2022-09-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.